• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Novartis

heart
Posted inClinical Trials, Metabolism

Merck & Co. Has Come Up With Very Powerful Pill Against ‘Bad’ Cholesterol

March 8, 2023March 8, 2023

MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.

heart
Posted inClinical Trials, Metabolism

Baxdrostat: New Treatment for Resistant Hypertension

November 29, 2022November 29, 2022

A selective aldosterone synthase inhibitor for significantly lowering blood pressure.

Psoriasis.
Posted inAutoimmune Diseases, New Drugs, Regulatory

Sotyktu: Miracle Pill for Autoimmune Diseases

September 10, 2022September 13, 2022

Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.

alopecia areata
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory

Alopecia Areata Treatment: What Future Holds

August 3, 2022September 8, 2022

What new drugs for hair loss are being developed by the pharmaceutical industry?

brain
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Ublyxi: Highly Effective Drug for Multiple Sclerosis

May 31, 2022September 8, 2022

Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.

heart
Posted inMetabolism, New Drugs, Regulatory

Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy

April 29, 2022September 8, 2022

Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.

Tepezza: First Drug for Thyroid Eye Disease
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory

Tepezza: First Drug for Thyroid Eye Disease

April 27, 2022September 12, 2022

Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.

Posts navigation

1 2 3 4 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News